Experimental liver cancer vaccine shows promise for young patients in early trial

An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for ...
TipRanks on MSN

Lunai Bioworks’ immune cell therapy shows tumor regression, wins first license

Lunai Bioworks (LNAI) has secured its first Letter of Intent, or LOI, to license its next-generation immune cell therapy, which achieved complete ...

Advancing patient-reported outcomes in cancer clinical trials

The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer ...
University of California

UCLA scientists develop one-product-fits-all immunotherapy for pancreatic cancer

UCLA researchers have developed a CAR-NKT cell therapy that has been more effective than current immunotherapies at fighting ...
Targeted Oncology

Dr Hinrichs on the Future of Cell Therapy Access: From Cancer Centers to Communities

Dr. Christian S. Hinrichs discusses the future of specialized cell therapies, predicting broader access for community clinics ...
Frontiers

Decoding Post-Translational Modifications in Cancer Progression, Immune Response, and Therapy Resistance

Cancer biology is a multidisciplinary field that continues to confront formidable challenges, with cancer ranking as a principal cause of global morbidity ...